HICKSVILLE, NY, May 15, 2018 (GLOBE NEWSWIRE) -- Canbiola, Inc. (OTC PINK: CANB), is pleased to announce a national partnership
with Strategic Medical Resources, LLC (SMR). SMR is managed by the founding partner Michael J. Bakke Sr. of the successful
behavioral health screening company GreenLight (GL). Mr. Bakke is joined at SMR by the former GreenLight National Sales Director Bob
Nieman and Director of Marketing Jim Stoltz. The SMR Team will be introducing Canbiola Organic CBD products to their physician
clients across 38 states.
Mr. Bakke states, “…the team now in place to distribute the complete line of Canbiola products not only have 100+ years of experience but also direct access to thousands of
doctors that we are sure will be excited to learn about Canbiola and to introduce these products to their patients which combined
is 100’s of thousands of new potential clients. We have done our extensive due diligence on all the available Hemp-based Organic
CBD products in the marketplace and have determined that Canbiola stands above the rest from a quality standpoint in addition to their high level of
customer service and professionality.”
“This by far is the largest distribution agreement the company has entered into to date, and we believe this deal has the
potential to add a high multiple on existing revenues and continue to propel the company on its path to becoming a nationally
recognizable brand,” says Marco Alfonsi, Canbiola CEO.
Strategic Medical Resources has hit the ground running marketing of Canbiola to its vast database, in combination with
Canbiola’s Products Distribution Network which already has a growing number of medical doctors distributing the Canbiola products
and our online sales, we expect to continuously fuel the growth of the company.
About GreenLight
GreenLight (GL) provides over 1,500,000 behavioral health screens for patients across 38 states. GreenLight continues their
efforts to improve patient outcomes through primary care physicians pain management, Ob/Gyn and numerous other medical specialties.
GreenLight is the number one provider of iPad delivered behavioral health screens in the country.
About Canbiola, Inc.
Canbiola, Inc. is a public company trading under symbol CANB.
Canbiola, Inc. is a US Company embarking in the sale of a variety of Cannabidiol (CBD) based products. Canbiola is in the
process of developing its own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and
the medical cannabis industry. Cannabis is currently federally illegal and has legalized for medical purposes in some form in a
limited number of states. The company has already launched several products found at www.canbiola.com.
The company also owns two technological solutions, Wrapmail (US Patent 8,572,275), which turns traditional email into a powerful
marketing and branding tool, as well Prosperity Systems and the Bullseye platform of document management and compliance targeted at
broker dealers, public companies, and governmental agencies providing a flawless all-in-one solution for document management,
retention and compliance.
Forward looking statements and risks and uncertainties Matters discussed in this press release contain forward-looking
statements. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such
forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated,
expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of
risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of
economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein
should not be construed in any way, shape or manner of our future financial condition or stock price.
CONTACT INFORMATION
Canbiola Investor Relations
Email:IR@canbiola.com
Phone: (516) 595-9544
Website: http://www.canbiola.com
Follow us on Twitter and Facebook
